J&J COVID-19 Vaccine Rollout Resumes In EU With New Rare Blood Clot Warning

Countries May Impose Age Restrictions

Janssen Pharmaceutica sign and logo
J&J hopes the EMA's review will reassure people in Europe that the vaccine is safe.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip